Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121007122 | 12100712 | 2 | F | 20160812 | 20160222 | 20160824 | PER | US-BAYER-2016-032529 | BAYER | 41.00 | YR | A | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121007122 | 12100712 | 1 | PS | ESTRADIOL. | ESTRADIOL | 1 | Transdermal | 0.06 MG, OW | Y | 20375 | .06 | MG | TRANSDERMAL PATCH | /wk | |||||
| 121007122 | 12100712 | 2 | SS | ESTRADIOL. | ESTRADIOL | 1 | Transdermal | 0.06 MG, OW | Y | 150192 | 20375 | .06 | MG | TRANSDERMAL PATCH | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121007122 | 12100712 | 1 | Hormone replacement therapy |
| 121007122 | 12100712 | 2 | Hormone replacement therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121007122 | 12100712 | Headache | |
| 121007122 | 12100712 | Product adhesion issue | |
| 121007122 | 12100712 | Product use issue | |
| 121007122 | 12100712 | Rash pruritic | |
| 121007122 | 12100712 | Scab |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121007122 | 12100712 | 1 | 2006 | 2006 | 0 |